Roger Sawhney's Insider Trades & SAST Disclosures
Roger Sawhney's most recent trade in Actuate Therapeutics Inc. was a trade of 30,000 Non-Qualified Stock Options done . Disclosure was reported to the exchange on Aug. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Roger Sawhney.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Actuate Therapeutics Inc. | Roger Sawhney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 30,000 | 30,000 | - | - | Non-Qualified Stock Options | |
| Alimera Sciences Inc. | Roger Sawhney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 2,252 | 2,252 | - | - | Stock Option (Right to Buy) | |
| Omega Therapeutics Inc | Roger Sawhney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 60,000 | 60,000 | - | - | Option (Right to Buy) | |
| Omega Therapeutics Inc | Roger Sawhney | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 03 Aug 2021 | 2,941 | 2,941 | - | 17 | 49,997 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges